NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Indian Stock Market Recap

Key Indicators:

  • Sensex: ended 0.7% higher on Tuesday, 17 March
  • Nifty: ended 0.7% higher on Tuesday, 17 March

Market Analysis

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

The Indian stock market benchmark indices, Sensex and Nifty, closed with gains on Tuesday, 17 March, following a positive trend in global peers. However, investor sentiment remained cautious due to ongoing concerns over the US-Iran conflict in the Middle East, a significant increase in crude oil prices, and a strong US dollar, which has dampened risk appetite.

Market Drivers

The ongoing US-Iran conflict, rising crude oil prices, and a strong US dollar have contributed to investor unease, leading to a cautious market environment. These factors have negatively impacted investor sentiment, despite the positive trend in global markets.

Investor Takeaway

Investors should remain cautious due to ongoing global concerns.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.